Elevated levels of a blood clotting factor linked to worse outcomes in severe COVID-19
Authors: MGH NEWS AND PUBLIC AFFAIRS This article is part of Harvard Medical School’s continuing coverage of medicine, biomedical research, medical education and policy related to the SARS-CoV-2 pandemic and the disease COVID-19. Patients hospitalized with severe COVID-19 infections who have high levels of the blood clotting protein factor V are at elevated risk for serious injury from blood […]